-
BKT140 (BL-8040) CXCR4 Research Workflows
2026-08-28
BKT140, also called BL-8040, enables functional CXCR4 studies that connect chemotaxis, apoptosis, tumor microenvironment biology, and stem cell mobilization. This practical guide outlines assay setup, formulation choices, translational applications, and troubleshooting strategies for oncology research.
-
Fluconazole Beyond Ergosterol: A Translational Roadmap
2026-08-28
Fluconazole remains a powerful mechanistic probe for ergosterol disruption, Candida biology, and antifungal drug resistance research. New evidence on the gut-secreted methyltransferase METTL9 adds a complementary host-defense dimension, suggesting how researchers can use fluconazole perturbation alongside nutritional-immunity assays to distinguish fungal adaptation from mucosal protection.
-
JC-1 and Ferroptosis: Reading Mitochondrial Stress
2026-08-27
JC-1 converts mitochondrial membrane potential changes into a red-to-green fluorescence signal that can strengthen ferroptosis, apoptosis detection, and cellular bioenergetics studies. This article explains how to interpret the probe as one component of a rigorous, multi-readout strategy inspired by pulmonary fibrosis research.
-
Oteseconazole: From CYP51 Selectivity to Assay Meaning
2026-08-27
Oteseconazole (VT-1161) is a selective tetrazole CYP51 inhibitor with strong activity across clinically relevant Candida species. This evidence-led guide explains how to interpret its mechanism, susceptibility data, resistance relevance, and translational value without conflating screening results with clinical conclusions.
-
Dorsomorphin (Compound C): AMPK and BMP Research
2026-08-26
Dorsomorphin, also called Compound C, is a reversible ATP-competitive AMPK inhibitor with additional activity against BMP signaling. Its dual pharmacology supports studies of metabolic signaling, autophagy regulation, cellular differentiation, and iron metabolism modulation, but it requires pathway-specific controls.
-
Putting Mammalian Embryonic Cells into Dormancy
2026-08-26
This Nature Protocols study translates pharmacological mTOR inhibition into reproducible in vitro workflows for inducing a reversible, diapause-like state in mouse blastocysts, human blastoids, and pluripotent stem cells. Its main contribution is a scalable alternative to invasive in vivo procedures, enabling mechanistic studies of developmental pausing while clearly defining the controls and readouts needed to distinguish dormancy from irreversible damage.
-
VX-765 for Caspase-1 and Pyroptosis
2026-08-25
VX-765 enables targeted investigation of caspase-1 signaling, cytokine maturation, and pyroptotic cell death across biochemical, macrophage, and disease-model workflows. Its active metabolite VRT-043198 supports potent pathway suppression, while recent evidence makes caspase-8 counter-screening essential for rigorous interpretation.
-
Pregnenolone Carbonitrile: PXR Assay Workflows
2026-08-25
Pregnenolone Carbonitrile connects rodent PXR activation with cytochrome P450 CYP3A induction, hepatic detoxification studies, and liver fibrosis research. Its emerging hypothalamic role also supports carefully controlled assays of AVP-linked water homeostasis, provided tissue, species, and genotype limitations are addressed.
-
Sulfaphenazole Derivatives Against TB with Lower CYP2C9
2026-08-24
The reference study optimized sulfaphenazole-derived sulfonamides to preserve antimycobacterial activity while reducing CYP2C9 inhibition, a potential source of drug–drug interactions. Compound 10d emerged as the leading example, combining a Mycobacterium tuberculosis MIC of 5.69 μg/mL with CYP2C9 inhibition weaker than 10 μM, providing a useful medicinal-chemistry framework for safer sulfonamide-based anti-TB discovery.
-
2,7-Dichlorodihydrofluorescein diacetate in PCOS
2026-08-24
A translational guide to using DCFH-DA as a context-aware intracellular ROS readout in granulosa-cell and PCOS research, connecting probe chemistry with THBS1/PI3K/AKT biology, assay controls, and the limits of mechanistic interpretation.
-
Oteseconazole: Translating CYP51 Selectivity Into Assays
2026-08-23
Oteseconazole (VT-1161) is more than a potent Candida-active azole: its fungal CYP51 selectivity creates a framework for better assay design and translational interpretation. This article connects mechanism, susceptibility testing, resistance biology, and the latest deuterated CYP51 inhibitor research.
-
PSPro Maps Spatial Proteomes at Cell-Type Resolution
2026-08-22
Mao et al. introduce PSPro, a proximity-labeling workflow that captures cell-type-specific proteomes directly from complex tissue slices while preserving spatial information. By combining optimized antibody-targeted labeling, affinity purification, and optional laser microdissection, the study profiles multiple cell types in pancreatic tumor and spleen tissue and resolves regional proteome heterogeneity.
-
RHO P347L Retinitis Pigmentosa: Endocytosis and Stress
2026-08-22
The 2026 study compares Class 1 RHO P347L and Class 2 RHO L125R mutations in humanized models to explain why P347L disease progresses more severely. Its evidence connects defective outer-segment trafficking, enhanced arrestin-associated endocytosis, lysosomal overload, and mitochondrial dysfunction, while indicating that neuroinflammation is a shared rather than severity-defining feature.
-
Epalrestat: Reframing Polyol Pathway Translation
2026-08-21
A translational framework for using Epalrestat to connect polyol pathway inhibition, oxidative stress research, diabetic neuropathy research, neuroprotection, and emerging questions in fructose-driven cancer metabolism.
-
5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
2026-08-20
This DMSO-soluble α2-adrenergic receptor agonist supports mechanistic studies of receptor signaling, immune rejection modulation, and post-surgical osteosarcoma recurrence models. The article translates reference findings into practical cell, hydrogel, and immune-assay workflows with troubleshooting guidance for solvent control, stability, and interpretation.